NCT05701384 2023-01-27Lazertinib 160mg in EGFR T790M NSCLCSamsung Medical CenterPhase 2 Unknown117 enrolled
NCT04829422 2022-03-03Early Access Program of Lazertinib in Republic of KoreaYuhan CorporationApproved for marketing